Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
40 hedge funds and large institutions have $246M invested in Vigil Neuroscience in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 0 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
8% more funds holding
Funds holding: 37 → 40 (+3)
0.08% more ownership
Funds ownership: 70.22% → 70.3% (+0.08%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
21% less capital invested
Capital invested by funds: $312M → $246M (-$66M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$802K |
| 2 |
Morgan Stanley
New York
|
+$554K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$352K |
| 4 |
Jane Street
New York
|
+$306K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$210K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$888K |
| 2 |
Goldman Sachs
New York
|
-$542K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$189K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$94.4K |
| 5 |
Citigroup
New York
|
-$28.4K |
VIGL Hedge Fund Activity: Q1 2023 in Review
40 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q1 2023, worth a combined $246M — down 21% from $312M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new VIGL positions and 0 closed out — a net gain of 3 holders — while 11 added to existing stakes and 10 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $802K. The largest seller was Deep Track Capital, cutting an estimated $888K.
- 40 institutional investors held Vigil Neuroscience (VIGL) as of Q1 2023, up from 37 in Q4 2022.
- Funds reported $246M of Vigil Neuroscience stock for Q1 2023, down 21% quarter-over-quarter.
- 3 funds opened new Vigil Neuroscience positions in Q1 2023 and 0 closed out, a net change of +3 holders.
- The largest Vigil Neuroscience buyer in Q1 2023 was Millennium Management, an estimated $802K added.
- The largest Vigil Neuroscience seller in Q1 2023 was Deep Track Capital, an estimated $888K sold.
Based on aggregated 13F filings for Q1 2023.